Related Experiment Video
Updated: Feb 11, 2026

09:15
Induction of Eryptosis in Red Blood Cells Using a Calcium Ionophore
Published on: January 21, 2020
9.3K
Thalassemias
Alissa Martin1, Alexis A Thompson
1Division of Hematology/Oncology, Ann and Robert H. Lurie Children's Hospital of Chicago, 225 East Chicago Avenue, Box #30, Chicago, IL 60611, USA.
Pediatric Clinics of North America
|November 19, 2013
Summary
Thalassemia syndromes are genetic hemoglobin disorders. This review covers diagnosis, complications, and management of chronic hemolytic anemia caused by reduced globin chain synthesis.
Area of Science:
- Hematology
- Genetics
- Internal Medicine
Background:
- Thalassemia syndromes are inherited blood disorders characterized by reduced or absent synthesis of alpha- or beta-globin chains.
- These genetic defects lead to chronic hemolytic anemia, ineffective erythropoiesis, and bone marrow overstimulation.
- Understanding the pathophysiology is crucial for managing affected individuals.
Purpose of the Study:
- To provide a comprehensive review of current diagnostic approaches for thalassemia.
- To outline the common complications associated with thalassemia syndromes.
- To discuss contemporary disease management strategies for thalassemia.
Main Methods:
- Literature review of diagnostic techniques for hemoglobin disorders.
- Analysis of clinical data regarding thalassemia complications.
- Synthesis of current treatment guidelines and therapeutic advancements.
Main Results:
- Diagnostic methods include genetic testing, hemoglobin electrophoresis, and blood counts.
- Complications encompass iron overload, bone deformities, and cardiovascular issues.
- Management involves blood transfusions, iron chelation therapy, and potentially stem cell transplantation.
Conclusions:
- Accurate diagnosis and proactive management are essential for improving outcomes in thalassemia patients.
- Multidisciplinary care is vital to address the complex complications of these lifelong conditions.
- Ongoing research aims to develop novel therapies for thalassemia.